NASDAQ : AUTL

Autolus Therapeutics plc — Company profile

Healthcare · Biotechnology · United Kingdom

Last price 1.52 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 404.57M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, a gene therapy product consisting of autologous T cells that are transduced with a lentiviral vector to express a novel anti-CD19 chimeric antigen receptor. It also develops obe-cel, which is in phase 1 to treat systemic lupus erythematosus, progressive multiple sclerosis, B-NHL and CLL, and CNS lymphoma; obe-cel, which is in phase 2 to treat pediatric B-ALL and lupus nephritis; AUTO1/22 to treat pediatric B-ALL, which is phase 1; AUTO8, which is in phase 1 to treat multiple myeloma and light chain amyloidosis; AUTO4/5, which is in preclinical stage to treat peripheral TCL; AUTO6NG, which is in phase 1 to treat neuroblastoma; and AUTO9, which is in preclinical stage to treat acute myeloid leukemia. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.

Details

NameAutolus Therapeutics plc
SectorHealthcare
IndustryBiotechnology
Employees754
Founded2014
Ipo Date2018-06-22
CeoChristian Itin
CountryUnited Kingdom
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS05280R1005
Cusip05280R100
Cik0001730463
Sic2836

Key executives

NameTitle
Dr. Christian Martin Itin Ph.D.Chief Executive Officer and Director
Dr. Martin Pule M.D., MBBSFounder, Senior Vice President and Chief Scientific Officer
Robert F. DolskiSenior Vice President and Chief Financial Officer
Christopher VannSenior Vice President and Chief Operating Officer
Patrick McIlvennySenior Vice President of Finance, Chief Accounting Officer and Principal Accounting Officer
Miranda NevilleSenior Vice President and Chief Technology Officer
Alex DriggsSenior Vice President of Legal Affairs and General Counsel and Secretary
Alexander SwanSenior Vice President and Chief Human Resources Officer
Dr. Christopher Williams Ph.D.Senior Vice President and Chief Business Development Officer
Dr. Matthias Will M.D.Senior Vice President and Chief Development Officer

Contact

AddressThe Mediaworks, 191 Wood Lane, London, W12 7FP, United Kingdom
Phone44 20 3829 6230
Websitehttps://www.autolus.com